Muir-Torre syndrome with intriguing squamous lesions: A case report and review of the literature

American Journal of Dermatopathology

Volumn 28, Issue 1, 2006, Pages 56-59

  Nishizawa, A ^a,b   Nakanishi, Y ^a   Sasajima, Y ^b   Yamazaki, N ^b   Yamamoto, A ^b  

^a NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^b NATIONAL CANCER CENTER HOSPITAL   (Japan)

Author keywords

Actinic keratosis; hMSH2 expression; Keratoacanthoma like squamous cell carcinoma; Muir Torre syndrome; Sebaceous neoplasm

Indexed keywords

PROTEIN MSH2; MSH2 PROTEIN, HUMAN; TUMOR MARKER;

ACTINIC KERATOSIS; ADULT; ANAMNESIS; ARTICLE; CANCER INVASION; CANCER SURGERY; CASE REPORT; COLORECTAL CANCER; ENDOMETRIUM CANCER; EPITHELIUM TUMOR; FEMALE; GENETIC PREDISPOSITION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MUIR TORRE SYNDROME; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEBACEOUS CARCINOMA; SKIN DEFECT; SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; CELL NUCLEUS; GENETICS; HETEROZYGOSITY LOSS; KERATOACANTHOMA; METABOLISM; MIDDLE AGED; PATHOLOGY; SEBACEOUS GLAND TUMOR; SYNDROME;

ADENOCARCINOMA, SEBACEOUS; CARCINOMA, SQUAMOUS CELL; CELL NUCLEUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATOACANTHOMA; LOSS OF HETEROZYGOSITY; MIDDLE AGED; MUTS HOMOLOG 2 PROTEIN; SEBACEOUS GLAND NEOPLASMS; SYNDROME; TUMOR MARKERS, BIOLOGICAL;

EID: 33745935776     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.dad.0000185146.83799.24     Document Type: Article

References (30)

1. Muir EG, Yates-Bell AJ, Barlow KA. Multiple primary carcinoma of colon, duodenum, and larynx associated with keratoakanthomata of the face. Br J Surg. 1967;54:191-195.
2. Torre D. Multiple sebaceous tumors. Arch Dermatol. 1968;98:549-551.
3. Lynch HT, Lynch PM, Pestel J, et al. The cancer family syndrome: rare cutaneous phenotypic linkage to Torre's syndrome. Arch Intern Med. 1981;141:607-611.
4. Hall NR, Murday VA, Chapman P, et al. Genetic linkage in Muir-Torre syndrome to the same chromosomal region as cancer family syndrome. Eur J Cancer. 1994;30:180-182.
5. Nyström-Lathi M, Parson R, Sistonen P, et al. Mismatch repair genes on chromosomes 2p and 3p account for a major share of hereditary non-polyposis colorectal cancer families evaluable by linkage. Am J Hum Genet. 1994;55:659-665.
6. Aaltonen LA, Petomäki P, Leach FS, et al. Clue to the pathogenesis of familial colorectal cancer. Science. 1993;260:812-816.
7. Thibodeau SN, Bren G, Schaid D. Microsatellite instability in cancer of the proximal colon. Science. 1993;260:816-819.
8. Ionov Y, Peinado MA, Malkhonsyan S, et al. Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature. 1993;363:558-561.
9. Honchel R, Halling KC, Schaid DJ, et al. Microsatellite instability in Muir-Torre syndrome. Cancer Res. 1994;54:1159-1163.
10. Kolodner RD, Hall NR, Lipford J, et al. Structure of the human MSH2 locus and analysis of two Muir-Torre kindreds for msh2 mutations. Genomics. 1994;24:516-526.
11. Mathiak M, Rutten A, Mangold E, et al. Loss of DNA mismatch repair proteins in skin tumors from patients with Muir-Torre syndrome and MSH2 or MLH1 germline mutations. Am J Surg Pathol. 2002;26:338-343.
12. Aaltonen LA, Salovaara R, Kristo P, et al. Incidence of hereditary non-polyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med. 1998;338:1481-1487.
13. Bapat BV, Madlensky L, Temple LK, et al. Family history characteristics, tumor microsatellite instability and germline MSH2 and MLH1 mutations in hereditary colorectal cancer. Hum Genet. 1999;104:167-176.
14. Leach FS, Nicolaides NC, Papadopoulos N, et al. Mutations of a mutS homolog in hereditary nonpolyposis colorectal cancer. Cell. 1993;75:1215-1225.
15. Liu B, Parsons R, Papadopoulos N, et al. Analysis of mismatch repair genes in hereditary non-polyposis colorectal cancer patients. Nat Med. 1996;2:169-174.
16. Wheeler JM, Loukola A, Aaltonen LA, et al. The role of hypermethylation of the hMLH1 promoter region in HNPCC versus MSI+ sporadic colorectal cancers. J Med Genet. 2000;37:588-592.
17. Kane MF, Loda M, Gaida GM, et al. Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res. 1997;57:808-811.
18. Herman JG, Umar A, Polyak K, et al. Incidence and functional consequences of hMLH1 promoter hypermethylation in colorectal carcinoma. Proc Natl Acad Sci USA. 1998;95:6870-6875.
19. Elder D, Elenitsas R, Ragsdale BD. Muir-Torre Syndrome. In: Histopathology of the Skin. 8th ed. Lever WF, Lever GS, eds. Philadelphia: J. B. Lippincott; 1997.
20. Sobin LH, Wittekind C, editors. UICC TNM Classification of Malignant Tumors. 6th ed. Wiley-Liss; 2002.
21. Vasen HFA, Mecklin J-P, Meera Khan P, et al. The International Collaborative Group on Hereditary Nonpolyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum. 1991;34:424-425.
22. Vasen HFA, Watson P, Mecklin J-P, et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC) proposed by the International Collaborative Group on HNPCC. Gastroenterology. 1999;116:1453-1456.
23. Fahmy A, Burgdorf WH, Schosser RH, et al. Muir-Torre syndrome: report of a case and reevaluation of the dermatopathologic feature. Cancer. 1982;49:1898-1903.
24. Akhtar S, Oza K, Khan S, et al. Case report of a patient with concurrent jejunal and ureteral cancer and review of literature. J Am Acad Dermatol. 1999;41:681-686.
25. Schwartz RA, Torre D. The Muir-Torre syndrome: a 25 year retrospect. J Am Acad Dermatol. 1995;33:90-104.
26. Putti CT, The M, Lee YS. Biological behavior of keratoacanthoma and squamous cell carcinoma: telomerase activity and COX-2 as potential markers. Mod Pathol. 2004;17:468-475.
27. Cooper PH, Wolfe JT. Perioral keratoacanthoma with extensive perineural invasion and intravenous growth. Arch Dermatol. 1988;124:1397-1401.
28. Calonje E, Jones EW. Intravascular spread of keratoacanthoma. An alarming but benign phenomenon. Am J Dermatopathol. 1992;14:414-417.
29. Schwartz RA, Goldberg DJ, Mahmood F, et al. The Muir-Torre syndrome: a disease of sebaceous and colonic neoplasms. Dermatologica. 1989;178:23-28.
30. Kruse R, Ruetten A, Lamberti C, et al. Muir-Torre phenotype has a frequency of DNA mismatch-repair-gene mutations similar to that in hereditary nonpolyposis colorectal cancer families defined by the Amsterdam criteria. Am J Hum Genet. 1998;63:63-70.